The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 15, 2016

Filed:

Jul. 10, 2013
Applicant:

Clemson University, Clemson, SC (US);

Inventors:

Agneta Simionescu, Pendleton, SC (US);

Dan Simionescu, Pendleton, SC (US);

James Chow, Columbia, SC (US);

Assignee:

Clemson University, Clemson, SC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/06 (2013.01); A61K 31/7024 (2006.01); A61K 31/7034 (2006.01); A61F 2/24 (2006.01); A61F 2/82 (2013.01); A61L 27/22 (2006.01); A61L 27/24 (2006.01); A61L 27/36 (2006.01); A61L 27/50 (2006.01); A61L 27/54 (2006.01); A61K 31/7032 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7034 (2013.01); A61F 2/24 (2013.01); A61F 2/82 (2013.01); A61K 31/7024 (2013.01); A61K 31/7032 (2013.01); A61L 27/227 (2013.01); A61L 27/24 (2013.01); A61L 27/3633 (2013.01); A61L 27/3683 (2013.01); A61L 27/3687 (2013.01); A61L 27/50 (2013.01); A61L 27/507 (2013.01); A61L 27/54 (2013.01); A61L 2300/216 (2013.01); A61L 2400/18 (2013.01); A61L 2430/20 (2013.01);
Abstract

Disclosed is a medical device treated with a phenolic compound and a process for treating a device with the phenolic compound. For example, a collagen or elastin-based scaffold can be treated with pentagalloyl glucose (PGG). The treated scaffold can become resistant to glycoxidative stress associated with advanced glycation end products (AGEs) that are present in a hyperglycemic environments associated with diabetes mellitus. The treated scaffold can exhibit a reduced increase in stiffness as compared to an untreated scaffold. The treated scaffold can also exhibit reduced inflammation without negatively affecting the ability of the scaffold to remodel in vivo.


Find Patent Forward Citations

Loading…